Long term investing works well, but it doesn't always work for each individual stock. We don't wish catastrophic capital loss on anyone. Imagine if you held Inogen, Inc. (NASDAQ:INGN) for half a ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters due to high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid third-quarter 2025 performance and ...

Inogen, Inc. INGN recently announced the launch of its Inogen One G5 portable oxygen concentrator. The product is now available for sale through the company’s domestic direct-to-consumer sales channel ...

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (NASDAQ: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced that its Board of ...

CEO Kevin Smith highlighted the company's Q1 2025 revenue of $82.3 million, reflecting a 5.5% year-over-year growth. He attributed this growth to strong performance in the business-to-business (B2B) ...

GOLETA, Calif.--(BUSINESS WIRE)--Inogen, Inc. (Nasdaq: INGN), a medical technology company offering innovative respiratory products for use in the homecare setting, today announced it has entered into ...

As the U.S. healthcare system continues to grapple with rising costs, an aging population, workforce shortages, and pressure ...

Inogen's price performance has been poor this year, but a closer look at the numbers suggests that the market's negativity may be unwarranted. Management is actively taking steps to address the ...

Inogen Inc (NASDAQ:INGN), a medical technology company, reported fourth-quarter 2023 revenues of $75.90 million, missing the consensus of $76.99 million. Fourth quarter total revenue fell from $88.1 ...

Sandra Gordon is a journalist specializing in health and medicine for consumers and healthcare providers. Her work has appeared in major magazines and websites, including Prevention, Parents, Medical ...

Inogen, Inc. INGN is well-poised for growth in the coming quarters, courtesy of high prospects in the portable oxygen concentrator (POC) space. The optimism, led by solid second-quarter 2024 ...